We have been able to show a high likelihood of the technology being able to reduce costs for the NHS, while improving the quality of care for patients.
The next step is to support the company in their ongoing clinical evaluation programme, in order to prove the deliverability of these benefits in a real-world context.
Hot off the press
We've just published a paper in the Journal of Medical Economics showing that adding the Parkinson’s KinetiGraph (the PKG, a wrist-worn movement recording device that collates continuous, objective, data during daily activities in people with Parkinson’s disease (PD) providing a report for clinicians) to standard monitoring of PD is a cost-effective option.